Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

By dosing mice with eyedrops containing gene probes that then travel to the brain, Harvard researchers are using magnetic resonance imaging to observe the brains of living animals. The method could allow doctors to directly diagnose problems such as tumors, viral infections, and head injury, without the need for a brain biopsy. It could also be useful in monitoring patients and perhaps even targeting drug treatment to affected areas of the brain.

The gene probe technique, reported in the latest issue of the Federation of American Societies for Experimental Biology Journal, allows MRI scans that show gliosis, the process in which glial cells in the brain form a fibrous network as a defense against damage. This scarring occurs in disorders such as Alzheimer’s disease and Parkinson’s disease and as a consequence of brain tumors and serious brain injury.

The work is “really a good start,” says Monique Stins, a visiting scientist at Johns Hopkins Medical Institutions, who was not involved in the research. However, she adds, “It’s still far from the bedside. The safety of all these kinds of probes still has to be assessed.”

In earlier studies, radiologist Philip Liu and his colleagues at Harvard Medical School injected the probes directly into the brains of animals. Now they’ve incorporated them into eyedrops.

To create the gene targeting probe, Liu and his colleagues hitched a common MRI probe to a DNA sequence complementary to the mRNA of a protein found in glial cells. They tested the probe in mice in which the blood-brain barrier–which regulates the movement of substances from the blood to the brain–had been breached. The barrier is compromised in many neurological disorders, including stroke, multiple sclerosis, and viral infections, although the process is not yet well understood.

Liu and his colleagues are not sure how the probes penetrated the brain, but they believe it may have been via the lymphatic system, which includes vessels in the eyes. Fluid from the lymphatic system merges with blood in the vascular system, and if the blood-brain barrier is compromised, Liu says, probes could travel from the eye to the brain.

After treating the mice with eyedrops, the team performed MRI scans on the live animals to produce images of gliosis in their brains. Such scans could be a valuable indicator of brain injury or a neurological disorder, Liu says, and they could be performed regularly to monitor a patient’s progress.

0 comments about this story. Start the discussion »

Credit: Courtesy Philip Liu of Harvard Medical School

Tagged: Biomedicine, MRI, tumor, Alzheimer’s, brain damage

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me
×

A Place of Inspiration

Understand the technologies that are changing business and driving the new global economy.

September 23-25, 2014
Register »